Wide Ranks

MEIP

MEI Pharma, Inc.

2.80

Top Statistics
Market Cap 18 M Forward PE -0.7547 Revenue Growth -100.00 %
Current Ratio 4.88 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 27.23 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.6600 Enterprise / Revenue -0.2670 Price To Sales Trailing12 Months 0.2857
Profitability
Profit Margins 27.23 % Operating Margins 39.81 %
Balance Sheet
Total Cash 38 M Total Cash Per Share 5.75 Total Debt
Total Debt To Equity Current Ratio 4.88 Book Value Per Share 4.96
All Measures
Short Ratio 94.00 % Message Board Id finmb_2214205 Shares Short Prior Month 19353
Return On Equity 0.6168 City San Diego Uuid 75f4e209-abec-388e-adff-b91ac3ee4681
Previous Close 2.84 First Trade Date Epoch Utc 1 B Book Value 4.96
Beta 0.7060 Volume 43769 Price To Book 0.5650
Last Split Date 1 B Fifty Two Week Low 2.61 Total Cash Per Share 5.75
Total Revenue 65 M Shares Short Previous Month Date 1 B Target Median Price 20.00
Max Age 86400 Recommendation Mean 3.00 Sand P52 Week Change 0.3133
Operating Margins 39.81 % Last Dividend Value 1.75 Target Mean Price 20.00
Net Income To Common 17 M Short Percent Of Float 0.0148 Implied Shares Outstanding 6 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 22180
Average Volume10days 22180 Total Cash 38 M Next Fiscal Year End 1 B
Revenue Per Share 9.80 Held Percent Insiders 0.0131 Ebitda Margins 40.40 %
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 2.84 Target Low Price 20.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 2.88 Open 2.83 Free Cashflow 12 M
State CA Dividend Yield 0.00 % Return On Assets 0.2004
Time Zone Short Name EST Trailing Eps -6.99 Day Low 2.76
Address1 9920 Pacific Heights Blvd. Shares Outstanding 6 M Price Hint 4
Target High Price 20.00 Website https://meipharma.com 52 Week Change -0.5440
Average Volume 44273 Forward Eps -3.71 Recommendation Key hold
Compensation As Of Epoch Date 1 B Quick Ratio 458.90 % Last Split Factor 1:20
Regular Market Day High 2.86 Is_sp_500 False Profit Margins 27.23 %
Fifty Two Week High 6.91 Day High 2.86 Shares Short 80970
Regular Market Open 2.83 Industry Key biotechnology Earnings Growth 0.00 %
Enterprise To Revenue -0.2670 Revenue Growth -100.00 % Shares Percent Shares Out 0.0122
Operating Cashflow -50473000 Currency USD Time Zone Full Name America/New_York
Market Cap 18 M Is_nasdaq_100 False Zip 92121
Quote Type EQUITY Industry Biotechnology Ex Dividend Date 1 B
Regular Market Day Low 2.76 Held Percent Institutions 0.4104 Long Name MEI Pharma, Inc.
Current Price 2.80 Address2 Suite 150 Enterprise To Ebitda -0.6600
Financial Currency USD Current Ratio 4.88 Gross Margins 75.54 %
Industry Disp Biotechnology Number Of Analyst Opinions 1 Country United States
Float Shares 4 M Two Hundred Day Average 3.22 Enterprise Value -17423630
Price To Sales Trailing12 Months 0.2857 Forward PE -0.7547 Regular Market Volume 43769
Last Dividend Date 1 B Ebitda 26 M Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer.

It develops ME-344, an intravenous small molecule inhibitor mitochondrial oxidative phosphorylation to treat human epidermal growth factor receptor 2 negative breast cancer, colorectal cancer, and solid tumors.

The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012.

MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California.